Tetrazole is an effective sn-3 phosphate replacement in substrate analog inhibitors of 14 kDa phospholipase A2

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 11, 1997, Pages 1427-1432

  Lee, Dennis ^a   Marshall, Lisa A ^a   Bolognese, Brian ^a   Adams, Jerry L ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE C4; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CHEMICAL MODIFICATION; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MONOCYTE; STRUCTURE ACTIVITY RELATION;

EID: 0030924641     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00247-3     Document Type: Article

References (29)

1. Kramer, R. M.; Hession, C.; Johansen, B.; Hayes, G.; McGray, P.; Chow, E. P.; Tizard, R.; Pepinski, R. B. J. Biol. Chem. 1989, 264, 5768. Seilhammer, J. J.; Pruzanski, W.; Vadas, P.; Plant, S.; Miller, J. A.; Kloss, J.; Johnson, L. K. J. Biol. Chem. 1989, 264, 5335.
2. Kramer, R. M.; Hession, C.; Johansen, B.; Hayes, G.; McGray, P.; Chow, E. P.; Tizard, R.; Pepinski, R. B. J. Biol. Chem. 1989, 264, 5768. Seilhammer, J. J.; Pruzanski, W.; Vadas, P.; Plant, S.; Miller, J. A.; Kloss, J.; Johnson, L. K. J. Biol. Chem. 1989, 264, 5335.
3. 2 in Clinical Inflammation. Molecular Approaches to Pathophysiology, Glaser, K. B.; Vadas, P., Ed.; CRC: Boca Raton, 1995; pp 25-51.
4. 2 in Clinical Inflammation. Molecular Approaches to Pathophysiology, Glaser, K. B.; Vadas, P., Ed.; CRC: Boca Raton, 1995; pp 25-51.
5. Nevalainen, T. J. Clin. Chem. 1993, 39, 2453.
6. 2 in Clinical Inflammation. Molecular Approaches to Pathophysiology, Glaser, K. B.; Vadas, P., Ed.; CRC: Boca Raton, 1995; pp 25-51.
7. 2 in Clinical Inflammation. Molecular Approaches to Pathophysiology, Glaser, K. B.; Vadas, P., Ed.; CRC: Boca Raton, 1995; pp 25-51.
8. Beaten, H. G.; Bennion, C.; Connolly, S.; Cook, A. R.; Gensmntel, N. P.; Hallam, C.; Hardy, K.; Hitchin, B.; Jackson, C. G.; Robinson, D. H. J. Med Chem. 1994, 37, 557.
9. Pisabarro, M. T.; Ortiz, A. R.; Palomer, A.; Cabre, F.; Garcia, L.; Wade, R. C.; Gago, F.; Mauleon, D.; Carganico, G. J. Med. Chem. 1994, 37, 337.
10. De Haas, G. H.; Dijkman, R.; Ransac, S.; Verger, R. Biochim. Biophys. Acta 1990, 1046, 249.
11. Yuan, W.; Quinn, D. M.; Sigler, P. B.; Gelb, M. H. Biochemistry 1990, 29, 6082.
12. Yu, L.; Dennis, E. A. J. Am. Chem. Soc. 1992, 114, 8758.
13. Yu, L.; Dennis, E. A. Proc. Natl. Acad Sci. U.S.A. 1991, 88, 9325.
14. Seyferth, D.; Weiner, M. A. J. Org. Chem. 1961, 26, 4797.
15. Hoye, T. R.; Crawford, K. B. J. Org. Chem. 1994, 59, 520.
16. Nwauka, S. O.; Lee, S.; Keehn, P. M. Synth. Commun. 1986, 16, 309,.
17. Banfi, A.; Benedini, F.; Sala, A. J. Het. Chem. 1991, 28, 401.
18. McCarthy, J. R.; Wiedeman, P. E.; Schuster, A. J.; Whitten, J. P.; Barbuch, R. J. J. Org. Chem. 1985, 50, 3095.
19. Mitsunobu, O.; Wada, M.; Sano, T. J. Am. Chem. Soc. 1972, 94, 679.
20. Rheenan, V. V.; Kelly, R. C.; Cha, D. Y. Tetrahedron Lett. 1976, 14, 1973.
21. Carlsen, P. H. J.; Katsuki, T.; Martin, V. S.; Sharpless, K. B. J. Org. Chem. 1981, 46, 3938.
22. Griffith, W. P.; Ley, S.; Whitcombe, G. P.; White, A. D. J. Chem. Soc., Chem. Commun. 1987, 1625.
23. Suzuki, H.; Sato, N.; Osuka, A. Chem. Lett., 1980, 143.
24. Vaultier, M.; Knouzi, N.; Carrie, R. Tetrahedron Lett. 1983, 24, 763.
25. Bayburt, T.; Yu, B.-Z.; Lin, H.-K.; Browning, J.; Jain, M. K.; Gelb, M. H. Biochemistry 1993, 32, 573.
26. Scott, D. L.; White, S. P.; Browning, J. L.; Rosa, J. J.; Gelb, M. H.; Sigler, P. B. Science 1991, 254, 1007.
27. A search of the Cambridge Structural Database turned up no examples of tetrazole-calcium ion interactions. However, several interactions involving calcium ions and imino nitrogens were found (D. Eggleston, unpublished results).
28. Both compounds were prepared in the same manner as that described for the preparations of 14 and 26, except 1-hexene oxide was used in place of 6.
29. Marshall, L. A.; Bolognese, B.; Raymond, H. Pharmacol. Commun. 1994, 5, 27.